Skip to content
You are now leaving to visit

Ionis appoints C. Frank Bennett, Ph.D., to chief scientific officer and promotes Eric E. Swayze, Ph.D., to senior vice president of research

New appointments effective January 1, 2020 CARLSBAD, Calif. , Dec. 18, 2019 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced the appointments of C. Frank Bennett , Ph.D., as chief scientific officer, and Eric E.